Location History:
- Winnewood, PA (US) (2017)
- Wynnewood, PA (US) (2023)
Company Filing History:
Years Active: 2017-2025
Title: Xianxin Hua: Innovator in Cancer Treatment Technologies
Introduction
Xianxin Hua is a prominent inventor based in Wynnewood, PA, specializing in innovative methods for cancer treatment. With a total of 4 patents, he has made significant contributions to the field of oncology, particularly in the development of targeted therapies.
Latest Patents
Hua's latest patents include groundbreaking compositions and methods for retrieving tumor-related antibodies and antigens. One notable invention is the Sequential Tumor-related Antibody and Antigen Retrieving (STAR) method, which efficiently identifies potent antibodies that specifically bind to tumor-related antigens on the surface of tumor cells. Another significant patent involves a CAR T system that targets CD13 to treat acute myeloid leukemia, as well as a CAR T system and ADC that targets CDH17 for treating neuroendocrine tumors and other malignancies expressing this antigen, all while maintaining tolerable toxicities. Additionally, he has developed compositions and methods for utilizing bispecific CARs to treat acute myeloid leukemia by binding to both CD13 and TIM-3 on AML cells.
Career Highlights
Xianxin Hua is affiliated with the University of Pennsylvania, where he conducts his research and development work. His innovative approaches have positioned him as a key figure in the advancement of cancer therapies.
Collaborations
Hua collaborates with esteemed colleagues, including Xin He and Shelley L. Berger, to further enhance the impact of his research in the field of cancer treatment.
Conclusion
Xianxin Hua's contributions to cancer treatment through his innovative patents and collaborative efforts highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies in oncology.